Effect of BRCA2 sequence variants predicted to disrupt exonic splice enhancers on BRCA2 transcripts

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Whiley, Phillip J ^a,b   Pettigrew, Christopher A ^a,c   Brewster, Brooke L ^a   Walker, Logan C ^b   Spurdle, Amanda B ^b   Brown, Melissa A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ALANINE; ASPARTIC ACID; BRCA2 PROTEIN; GLUTAMIC ACID; GLYCINE; GUANINE; HISTIDINE; MESSENGER RNA; SERINE; THREONINE; THYMINE; BRCA1 PROTEIN;

ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; ENHANCER REGION; EXON; GENE DISRUPTION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; PREDICTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRANS SPLICING; BIOLOGY; BREAST TUMOR; FEMALE; GENETICS; METABOLISM; MUTATION; RNA SPLICING; TUMOR CELL LINE;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; EXONS; FEMALE; GENETIC VARIATION; HUMANS; MUTATION; RNA SPLICING; RNA, MESSENGER;

EID: 77952725403     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-80     Document Type: Article

References (21)

1. Spurdle AB, Couch FJ, Hogervorst FB, Radice P, Sinilnikova OM. Prediction and assessment of splicing alterations: implications for clinical testing. Hum Mutat 2008, 29:1304-13. 10.1002/humu.20901, 2832470, 18951448.
2. Yang Y, Swaminathan S, Martin BK, Sharan SK. Aberrant splicing induced by missense mutations in BRCA1: clues from a humanized mouse model. Hum Mol Genet 2003, 12:2121-2131. 10.1093/hmg/ddg222, 12915465.
3. Liu HX, Cartegni L, Zhang MQ, Krainer AR. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 2001, 27:55-8.
4. Fackenthal JD, Cartegni L, Krainer AR, Olopade OI. BRCA2 T2722R is a deleterious allele that causes exon skipping. American Journal Of Human Genetics 2002, 71:625-631. 10.1086/342192, 379197, 12145750.
5. Farrugia DJ, Agarwal MK, Pankratz VS, Deffenbaugh AM, Pruss D, Frye C, Wadum L, Johnson K, Mentlick J, Tavtigian SV, Goldgar DE, Couch FJ. Functional assays for classification of BRCA2 variants of uncertain significance. Cancer Res 2008, 68:3523-31. 10.1158/0008-5472.CAN-07-1587, 18451181.
6. Millevoi S, Bernat S, Telly D, Fouque F, Gladieff L, Favre G, Vagner S, Toulas C. The c.5242C > A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding. Breast Cancer Res Treat 2009,
7. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Reviews Genetics 2002, 3:285-298. 10.1038/nrg775, 11967553.
8. Pettigrew CA, Wayte N, Lovelock PK, Tavtigian SV, Chenevix-Trench G, Spurdle AB, Brown MA. Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms. Breast Cancer Research: BCR 2005, 7:R929-39. 10.1186/bcr1324, 1410749, 16280041.
9. Gorlov IP, Gorlova OY, Frazier ML, Amos CI. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs). Mutat Res 2004, 554:175-83.
10. Pettigrew CA, Wayte N, Wronski A, Lovelock PK, Spurdle AB, Brown MA. Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variants. Breast Cancer Res Treat 2008, 110:227-34. 10.1007/s10549-007-9714-5, 17899372.
11. den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet 2001, 109:121-4. 10.1007/s004390100505, 11479744.
12. Lastella P, Surdo NC, Resta N, Guanti G, Stella A. In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects. BMC Genomics 2006, 7:243. 10.1186/1471-2164-7-243, 1590028, 16995940.
13. Anczukow O, Buisson M, Salles MJ, Triboulet S, Longy M, Lidereau R, Sinilnikova OM, Mazoyer S. Unclassified variants identified in BRCA1 exon 11: Consequences on splicing. Genes Chromosomes Cancer 2008, 47:418-26. 10.1002/gcc.20546, 18273839.
14. Bonnet C, Krieger S, Vezain M, Rousselin A, Tournier I, Martins A, Berthet P, Chevrier A, Dugast C, Layet V, Rossi A, Lidereau R, Frebourg T, Hardouin A, Tosi M. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. J Med Genet 2008, 45:438-46. 10.1136/jmg.2007.056895, 18424508.
15. Brown MA, Jones KA, Nicolai H, Bonjardim M, Black D, McFarlane R, de Jong P, Quirk JP, Lehrach H, Solomon E. Physical mapping, cloning, and identification of genes within a 500-kb region containing BRCA1. Proc Natl Acad Sci USA 1995, 92:4362-6. 10.1073/pnas.92.10.4362, 41944, 7753812.
16. Bonatti F, Pepe C, Tancredi M, Lombardi G, Aretini P, Sensi E, Falaschi E, Cipollini G, Bevilacqua G, Caligo MA. RNA-based analysis of BRCA1 and BRCA2 gene alterations. Cancer Genetics And Cytogenetics 2006, 170:93-101. 10.1016/j.cancergencyto.2006.05.005, 17011978.
17. Tesoriero AA, Wong EM, Jenkins MA, Hopper JL, Brown MA, Chenevix-Trench G, Spurdle AB, Southey MC. Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families. Hum Mutat 2005, 26:495-495. 10.1002/humu.9379, 16211554.
18. Burn TC, Connors TD, Klinger KW, Landes GM. Increased exon-trapping efficiency through modifications to the pSPL3 splicing vector. Gene 1995, 161:183-7. 10.1016/0378-1119(95)00223-S, 7665076.
19. Caux-Moncoutier V, Pages-Berhouet S, Michaux D, Asselain B, Castera L, De Pauw A, Buecher B, Gauthier-Villars M, Stoppa-Lyonnet D, Houdayer C. Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study. Eur J Hum Genet 2009,
20. Fairbrother WG, Yeh RF, Sharp PA, Burge CB. Predictive identification of exonic splicing enhancers in human genes. Science 2002, 297:1007-13. 10.1126/science.1073774, 12114529.
21. Zatkova A, Messiaen L, Vandenbroucke I, Wieser R, Fonatsch C, Krainer AR, Wimmer K. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1. Hum Mutat 2004, 24:491-501. 10.1002/humu.20103, 15523642.